Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Joubert

Showing results (41-50 of 163) with videos related to

Pageof 17
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2016
Transcriptomic Microenvironment of Lung AdenocarcinomaYohan Bossé, Olga Sazonova, Nathalie Gaudreault, et al.
Clinical Case Reports|January 31, 2020
Is heart transplantation a valuable option in patients with diffuse systemic sclerosis and primary cardiac involvement?Frédéric Turcotte-Gosselin, Pierre Yves Turgeon, Alena Ikic, et al.
International Journal of Oncology|December 25, 2013
Identification of KvLQT1 K+ channels as new regulators of non-small cell lung cancer cell proliferation and migrationAlban Girault, Anik Privé, Nguyen Thu Ngan Trinh, et al.
Plos One|November 30, 2021
Countering the advert effects of lung cancer on the anticancer potential of dendritic cell populations reinstates sensitivity to anti-PD-1 therapyJulyanne Brassard, Meredith Elizabeth Gill, Emilie Bernatchez, et al.
Cancers|August 27, 2021
ZNF768 Expression Associates with High Proliferative Clinicopathological Features in Lung AdenocarcinomaAudrey Poirier, Andréanne Gagné, Philippe Laflamme, et al.
Oncotarget|February 22, 2021
Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumorsVenkata S K Manem, Olga Sazonova, Andréanne Gagné, et al.
Oncotarget|December 6, 2022
Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumorsVenkata S K Manem, Olga Sazonova, Andréanne Gagné, et al.
Human Pathology|October 2, 2020
Phospho-histone-H3 immunostaining for pulmonary carcinoids: impact on clinical appraisal, interobserver correlation, and diagnostic processing efficiencyPhilippe Laflamme, Babak K Mansoori, Olga Sazanova, et al.
Lung Cancer (Amsterdam, Netherlands)|April 10, 2025
Frequency of targetable genetic alterations in resectable lung adenocarcinoma: Results from the LORD projectYohan Bossé, Dominique K Boudreau, Victoria Saavedra Armero, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2019
Impact of Specimen Characteristics on PD-L1 Testing in Non-Small Cell Lung Cancer: Validation of the IASLC PD-L1 Testing RecommendationsAndréanne Gagné, Emily Wang, Nathalie Bastien, et al.
Pageof 17

Showing results (41-50 of 163) with videos related to

Sort By:
Pageof 17
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2016
Transcriptomic Microenvironment of Lung AdenocarcinomaYohan Bossé, Olga Sazonova, Nathalie Gaudreault, et al.
Clinical Case Reports|January 31, 2020
Is heart transplantation a valuable option in patients with diffuse systemic sclerosis and primary cardiac involvement?Frédéric Turcotte-Gosselin, Pierre Yves Turgeon, Alena Ikic, et al.
International Journal of Oncology|December 25, 2013
Identification of KvLQT1 K+ channels as new regulators of non-small cell lung cancer cell proliferation and migrationAlban Girault, Anik Privé, Nguyen Thu Ngan Trinh, et al.
Plos One|November 30, 2021
Countering the advert effects of lung cancer on the anticancer potential of dendritic cell populations reinstates sensitivity to anti-PD-1 therapyJulyanne Brassard, Meredith Elizabeth Gill, Emilie Bernatchez, et al.
Cancers|August 27, 2021
ZNF768 Expression Associates with High Proliferative Clinicopathological Features in Lung AdenocarcinomaAudrey Poirier, Andréanne Gagné, Philippe Laflamme, et al.
Oncotarget|February 22, 2021
Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumorsVenkata S K Manem, Olga Sazonova, Andréanne Gagné, et al.
Oncotarget|December 6, 2022
Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumorsVenkata S K Manem, Olga Sazonova, Andréanne Gagné, et al.
Human Pathology|October 2, 2020
Phospho-histone-H3 immunostaining for pulmonary carcinoids: impact on clinical appraisal, interobserver correlation, and diagnostic processing efficiencyPhilippe Laflamme, Babak K Mansoori, Olga Sazanova, et al.
Lung Cancer (Amsterdam, Netherlands)|April 10, 2025
Frequency of targetable genetic alterations in resectable lung adenocarcinoma: Results from the LORD projectYohan Bossé, Dominique K Boudreau, Victoria Saavedra Armero, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2019
Impact of Specimen Characteristics on PD-L1 Testing in Non-Small Cell Lung Cancer: Validation of the IASLC PD-L1 Testing RecommendationsAndréanne Gagné, Emily Wang, Nathalie Bastien, et al.
Pageof 17